Professor Hani Gabra

Consultant Medical Oncologist


"Spire Portsmouth is an excellent environment for patients with friendly, knowledgeable and efficient staff."

Specialises in

I have been a consultant medical oncologist specialising in gynaecological cancer (ovarian, uterine and cervical cancer), personalised cancer medicine, and cancer of unknown primary for 23 years. Initially 1998-2003 at the Western General Hospital in Edinburgh, at Imperial College London from 2003-21 and since June 2021 at Portsmouth Hospitals University NHS Trust. I am Portsmouth Hospitals University NHS Trust’s Lead Cancer Clinician.

I was Professor of Medical Oncology 2003-2020 at Imperial College London and since 2020 Professor Emeritus in Medical Oncology at Imperial College London. Since 2017 I have also had deep experience of early clinical drug development in a pharma and biotech setting, first as a Vice President in early clinical development at Astra Zeneca and then as Chief Medical Officer and Head of clinical development at BerGenBio, a clinical stage biotech company. I am also the founder of the biotech company Papyrus Therapeutics, based in the USA.

As well as being Professor Emeritus at Imperial College, I am also Adjunct Professor in Personalised Cancer Medicine at the University of Bergen, Norway and I hold a Visiting Professorship in Gynaecological Cancer at the Guanxi Medical University in Nanning, China.

Previously I held senior leadership roles at Imperial College including that of Director of the Ovarian Cancer Action Research Centre, Deputy Head of the Division of Cancer at Imperial College, Head of NHS Medical Oncology and Chief of Service for Gynaecological Cancer at Imperial College NHS Trust. I was a committee member of the Cancer Research UK’s CTAAC funding committee and the French INCa national research funding committee for five years.


Treatment information

Some of the principal treatments carried out by Professor Hani Gabra at Spire include:

Clinical oncology

Other treatments

Systemic treatment of cancer, targeted therapy and endocrine therapy

Get in touch

Important information about Covid-19 tests

COVID-19 testing or antibody tests are not available as a standalone service at Spire Portsmouth Hospital.


Marketing Information

Spire would like to provide you with marketing information about products and services offered by Spire and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.

Submit my enquiry

Additional information

Gynaecological cancer

Gynaecological Medical Oncology, Ovarian Cancer, Uterine Cancer, Cervical Cancer, Personalised Cancer Medicine

B.Sc. (Hons) / University of Glasgow / 1984
Honours degree in Molecular Biology

MB, ChB / University of Glasgow / 1987
Degrees in Medicine and Surgery

MRCP / United Kingdom / 1990
Member of the Royal College of Physicians

MSc / University of Edinburgh / 1993
Clinical Oncology

Ph.D / University of Edinburgh / 1997
Thesis: “Molecular and Cell Genetic Analysis of chromosome 11 in sporadic epithelial ovarian cancer”. Supervisor: Prof David Porteous

CCST (Med Oncol) / United Kingdom / 1998
General Medical Council Certificate of Completion of Specialist Training

FRCP (Edin) / Edinburgh / 2003
3 Fellow of the Royal College of Physicians of Edinburgh.

FRCP (Lond) / London / 2005
Fellow of the Royal College of Physicians of London

Professional memberships

American Society of Clinical Oncology

American Association for Cancer Research

European Society of Gynaecological Oncology

International Gynecologic Cancer Society

European Society for Medical Oncology

British Gynaecological Cancer Society

Professional leadership

Portsmouth Hospitals University NHS Trust Lead Cancer Clinician

Consultant Medical Oncologist, Portsmouth Hospitals University NHS Trust
Professor Emeritus in Medical Oncology, Imperial College London
Honorary Consultant in Medical Oncology, Imperial College Healthcare NHS trust

Part time positions as Director in Early Clinical Drug Development at BerGenBio , and as Founder, Board Member and Chief Scientific Officer of Papyrus Therapeutics.
Private secretary Amber Cosgrave
Private secretary telephone 02392 286 050
Private secretary email